Sanara MedTech Inc. Common Stock earnings per share and revenue
On Jan 23, 2026, SMTI reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of 0.33 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 28.33 million, with a --% difference. The market reacted with a -2.30% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of 0.07 USD, with revenue projected to reach 28.66 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
$0.01
Surprise
0.00%
Abbott Laboratories
Report Date
Jan 22, 2026 For Q4 25
Estimate
$1.51
Actual
$1.50
Surprise
-0.75%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
FAQ
What were Sanara MedTech Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Sanara MedTech Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Sanara MedTech Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -2.3%, changed from $21.75 before the earnings release to $21.25 the day after.
When is Sanara MedTech Inc. Common Stock expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for Sanara MedTech Inc. Common Stock's next earnings report?
Based on 4
analysts, Sanara MedTech Inc. Common Stock is expected to report EPS of $0.07 and revenue of $28.66M for Q1 2026.